These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 17400308)
1. Simultaneous hemodynamic and serological cardiotoxicity monitoring during immunotherapy with trastuzumab. Knobloch K; Tepe J; Lichtinghagen R; Luck HJ; Vogt PM Int J Cardiol; 2008 Mar; 125(1):113-5. PubMed ID: 17400308 [TBL] [Abstract][Full Text] [Related]
2. Combined NT-pro-BNP and CW-Doppler ultrasound cardiac output monitoring (USCOM) in epirubicin and liposomal doxorubicin therapy. Knobloch K; Tepe J; Rossner D; Lichtinghagen R; Luck HJ; Busch KH; Vogt PM Int J Cardiol; 2008 Aug; 128(3):316-25. PubMed ID: 17707098 [TBL] [Abstract][Full Text] [Related]
3. Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancer. Goel S; Simes RJ; Beith JM Asia Pac J Clin Oncol; 2011 Sep; 7(3):276-80. PubMed ID: 21884439 [TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration. Ballotta A; Ranucci M; Kunkl A; El Baghdady H; Bossone E; Castelvecchio S; Frigiola A; Menicanti L; Di Donato M; Mehta RH Am J Cardiol; 2010 Mar; 105(5):640-4. PubMed ID: 20185010 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery. Goei D; van Kuijk JP; Flu WJ; Hoeks SE; Chonchol M; Verhagen HJ; Bax JJ; Poldermans D Am J Cardiol; 2011 Feb; 107(4):609-14. PubMed ID: 21185000 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery. Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130 [TBL] [Abstract][Full Text] [Related]
7. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Goei D; Schouten O; Boersma E; Welten GM; Dunkelgrun M; Lindemans J; van Gestel YR; Hoeks SE; Bax JJ; Poldermans D Am J Cardiol; 2008 Jan; 101(1):122-6. PubMed ID: 18157978 [TBL] [Abstract][Full Text] [Related]
8. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance. Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423 [TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer. Fiúza M Adv Ther; 2009 Jul; 26 Suppl 1():S9-17. PubMed ID: 19669637 [TBL] [Abstract][Full Text] [Related]
10. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932 [TBL] [Abstract][Full Text] [Related]
11. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines. Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels. Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726 [TBL] [Abstract][Full Text] [Related]
13. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560 [TBL] [Abstract][Full Text] [Related]
14. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels. Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease. Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308 [TBL] [Abstract][Full Text] [Related]
16. Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure. Araújo JP; Azevedo A; Lourenço P; Rocha-Gonçalves F; Ferreira A; Bettencourt P Am J Cardiol; 2006 Nov; 98(9):1248-50. PubMed ID: 17056340 [TBL] [Abstract][Full Text] [Related]
17. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock. Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555 [TBL] [Abstract][Full Text] [Related]
18. No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure. Nilsson BB; Westheim A; Risberg MA; Arnesen H; Seljeflot I Scand Cardiovasc J; 2010 Aug; 44(4):223-9. PubMed ID: 20636229 [TBL] [Abstract][Full Text] [Related]
19. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]